Researchers Submit Patent Application, 'Tricyclic Heterocycle Compounds Useful As Hiv Integrase Inhibitors', for Approval (USPTO 20210361662)

MLA

“Researchers Submit Patent Application, ’Tricyclic Heterocycle Compounds Useful As Hiv Integrase Inhibitors’, for Approval (USPTO 20210361662).” Obesity, Fitness & Wellness Week, Dec. 2021, p. 1480. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.686495904&authtype=sso&custid=ns315887.

APA

Researchers Submit Patent Application, ’Tricyclic Heterocycle Compounds Useful As Hiv Integrase Inhibitors’, for Approval (USPTO 20210361662). (2021, December 18). Obesity, Fitness & Wellness Week, 1480.

Chicago

Obesity, Fitness & Wellness Week. 2021. “Researchers Submit Patent Application, ’Tricyclic Heterocycle Compounds Useful As Hiv Integrase Inhibitors’, for Approval (USPTO 20210361662),” December 18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.686495904&authtype=sso&custid=ns315887.